Skip to content
stoqly

Primerica

PRI NYSE Life & Health Insurance Financials FY2016–FY2025

Primerica's revenue rose 6.6% to $3.3 billion in fiscal 2025. Its net margin was 22.8%, up from 15.2% a year earlier. It paid out $586 million in dividends and buybacks. The diluted share count fell 4.4%.

Last close Β· Oct 23, 2026

$274.43

4.0%
Revenue Total sales reported in the income statement.
$3.3B
6.6% vs prior year
Operating margin Operating income as a share of revenue.
β€”
Net income Profit after all expenses, interest and tax.
$751M
59.7%
Free cash flow Cash from operations minus capital spending.
β€”
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
34.5%
0.4 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$8.6B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
11.0x
On $24.89 EPS (TTM)

About these figures. Debt is Primerica's notes payable, its senior notes; its 2021 filing tags them under another label. Primerica's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.

What Primerica does

No business description yet.

Legal name
Primerica, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0001193125-26-082233
0001475922

Revenue and margins

Primerica had $3.3B of revenue in fiscal 2025, up 6.6% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 19.6% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was β€” in fiscal 2025, β€” of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Primerica returned $586M to shareholders in fiscal 2025. The diluted share count fell 4.4%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Primerica yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of $160M and divides by 32.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 11.0x Β· peers 14.4x Β· sector 13.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably Primerica can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $478M$559M$594M$688M$756M
Debt incl. finance leases $593M$594M$594M$596M$596M
Net debt / EBITDA 0.2x0.0x0.0xβˆ’0.1xβˆ’0.2x
Debt / equity 0.6x0.3x0.3x0.3x0.2x
Interest coverage 22.0x27.4x30.0x39.8x43.2x
Total assets $16.2B$14.6B$15.0B$14.6B$15.0B
Total liabilities $14.0B$12.6B$13.0B$12.3B$12.6B
Shareholders' equity $925M$2.0B$2.1B$2.3B$2.4B
Net debt (βˆ’ = net cash) $115M$35.1Mβˆ’$0.2Mβˆ’$92.3Mβˆ’$160M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$4.5M

5 insiders

Of sales under plans

93%

$4.2M

DateInsiderTradeSharesPriceValueFiling
Aug 17, 2026 Peter W. SchneiderPresident Sold plan 1,800 $312.65 $0.6M Form 4
Aug 11, 2026 Amber Lynne CottleDirector Sold 279 $313.63 $0.1M Form 4
Aug 10, 2026 Glenn J. WilliamsChief Executive Officer, Director Sold plan 1,500 $320.20 $0.5M Form 4
Jun 12, 2026 Glenn J. WilliamsChief Executive Officer, Director Sold plan 1,500 $280.49 $0.4M Form 4
May 18, 2026 Peter W. SchneiderPresident Sold plan 1,800 $279.64 $0.5M Form 4
Mar 10, 2026 Peter W. SchneiderPresident Sold plan 1,800 $252.38 $0.5M Form 4
Mar 2, 2026 Nicholas Adam JendusaPrincipal Accounting Officer Sold 190 $255.51 $0.0M Form 4
Feb 17, 2026 Glenn J. WilliamsChief Executive Officer, Director Sold plan 2,500 $256.41 $0.6M Form 4
Dec 3, 2025 Joel M. BabbitDirector Sold 700 $255.00 $0.2M Form 4
Nov 17, 2025 Peter W. SchneiderPresident Sold plan 2,000 $255.30 $0.5M Form 4
Nov 12, 2025 Glenn J. WilliamsChief Executive Officer, Director Sold plan 2,500 $259.65 $0.6M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ• βœ•
Current ratio rose β€” β€” β€”
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose βœ“ β€” β€”
Revenue rose relative to assets βœ“ βœ“ βœ“
F-score β€” / 9β€” / 9β€” / 9
Accruals ratio βˆ’0.8%βˆ’2.6%βˆ’1.0%
Altman Z'' β€”β€”β€”

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Primerica PRI $8.6B 6.6% β€” β€” 34.5% 11.0x β€”
CNO Financial Group CNO $5.1B 0.9% 12.3% β€” β€” 18.4x β€” Compare β†’
Globe Life GL $12.2B 3.7% β€” 20.9% 16.0% 10.3x β€” Compare β†’
Brighthouse Financial BHF $2.6B 43.2% β€” β€” β€” 3.6x β€” Compare β†’
Unum UNM $14.4B 1.5% β€” 4.3% 7.6% 21.0x β€” Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.5B $1.7B $1.9B $2.1B $2.2B $2.7B $2.7B $2.7B $3.1B $3.3B
Gross profit β€” β€” β€” β€” β€” $2.7B $2.6B $2.7B β€” β€”
Interest expense $28.7M $28.5M $28.8M $28.8M $28.8M $30.6M $27.2M $26.6M $24.2M $23.1M
Pretax income $338M $380M $416M $477M $507M $644M $719M $772M $939M $975M
Income tax $118M $29.3M $92.0M $111M $121M $168M $164M $181M $219M $223M
Net income $219M $350M $324M $366M $386M $477M $472M $577M $471M $751M
Diluted EPS $4.59 $7.61 $7.33 $8.62 $9.57 $11.99 $12.33 $15.94 $13.71 $22.91
Diluted shares 0.05B 0.05B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.03B 0.03B
Cash flow
Cash from operations $294M $392M $478M $486M $643M $657M $758M $693M $862M $901M
Depreciation and amortization $14.6M $13.6M $12.4M $18.3M $17.7M $29.8M $34.2M $32.0M $23.4M $19.3M
Stock-based compensation $13.4M $15.3M $17.3M $17.5M $19.0M $16.8M $22.4M $18.9M $25.1M $24.6M
Acquisitions $0.0M $0.0M $0.0M $0.0M $0.0M $495M $3.9M $0.0M $0.0M $0.0M
Share buybacks $150M $150M $210M $225M $231M $18.8M $356M $375M $425M $450M
Dividends paid $33.4M $35.8M $44.1M $57.6M $64.3M $74.6M $83.8M $93.7M $113M $136M
Dividends and buybacks $183M $186M $254M $283M $296M $93.4M $440M $469M $538M $586M
Balance sheet
Cash and short-term investments $212M $280M $270M $257M $548M $478M $559M $594M $688M $756M
Total debt $373M $373M $374M $374M $374M $592M $593M $594M $595M $595M
Finance lease liabilities $0.0M $0.0M $0.0M $0.7M $0.9M $1.0M $0.8M $0.5M $1.0M $1.0M
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Property and equipment, net $27.5M $28.1M $36.0M $46.1M $57.7M $67.0M $52.7M $37.6M $40.7M $39.8M
Total assets $11.4B $12.5B $12.6B $13.7B $14.9B $16.2B $14.6B $15.0B $14.6B $15.0B
Total liabilities $10.2B $11.0B $11.1B $12.0B $13.1B $14.0B $12.6B $13.0B $12.3B $12.6B
Shareholders' equity $1.2B $1.4B $1.5B $1.7B $1.8B $925M $2.0B $2.1B $2.3B $2.4B
Margins
Gross margin β€” β€” β€” β€” β€” 98.1% 97.4% 98.0% β€” β€”
EBITDA margin 25.1% 25.0% 24.1% 25.5% 25.0% 26.0% 29.4% 30.2% 32.0% 30.9%
Net margin 14.4% 20.7% 17.1% 17.9% 17.4% 17.6% 17.8% 21.0% 15.2% 22.8%
Returns
Return on capital 17.3% 26.0% 22.5% 23.3% 23.8% β€” 37.1% 29.6% 34.9% 34.5%
Return on equity 18.5% 26.5% 22.5% 23.5% 22.1% 34.6% 31.9% 28.2% 21.8% 31.9%
Return on assets 2.0% 2.9% 2.6% 2.8% 2.7% 3.1% 3.1% 3.9% 3.2% 5.1%
Growth
Revenue growth 8.2% 11.2% 12.5% 8.0% 8.0% 22.2% βˆ’1.9% 3.4% 12.4% 6.6%
Net income growth 15.6% 59.6% βˆ’7.5% 13.1% 5.4% 23.6% βˆ’1.1% 22.1% βˆ’18.4% 59.7%
EPS growth 24.1% 65.8% βˆ’3.7% 17.6% 11.0% 25.3% 2.8% 29.3% βˆ’14.0% 67.1%
Share count change βˆ’6.8% βˆ’3.7% βˆ’3.7% βˆ’3.8% βˆ’5.0% βˆ’1.3% βˆ’3.9% βˆ’5.5% βˆ’5.1% βˆ’4.4%
Financial health
Net debt / EBITDA 0.4x 0.2x 0.2x 0.2x βˆ’0.3x 0.2x 0.0x 0.0x βˆ’0.1x βˆ’0.2x
Debt / equity 0.3x 0.3x 0.3x 0.2x 0.2x 0.6x 0.3x 0.3x 0.3x 0.2x
Interest coverage 12.8x 14.3x 15.4x 17.6x 18.6x 22.0x 27.4x 30.0x 39.8x 43.2x
Capital allocation
Stock comp / revenue 0.9% 0.9% 0.9% 0.9% 0.9% 0.6% 0.8% 0.7% 0.8% 0.8%
Quality scores
Accruals ratio βˆ’0.7% βˆ’0.4% βˆ’1.2% βˆ’0.9% βˆ’1.8% βˆ’1.2% βˆ’1.9% βˆ’0.8% βˆ’2.6% βˆ’1.0%

Source: SEC EDGAR XBRL filings (CIK 0001475922). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open